Renaissance Technologies
INBX icon

Renaissance Technologies’s Inhibrx INBX Stock Holding History

Renaissance Technologies’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37M Sell
50,183
-2,417
-5% -$179K 0.01% 1596
2025
Q4 		$4.16M Buy
52,600
+44,200
+526% +$3.01M 0.01% 1407
2025
Q3 		$283K Buy
+8,400
New +$207K ﹤0.01% 3022
2024
Q4 		– Sell
-25,100
Closed -$393K – 3726
2024
Q3 		$393K Buy
+25,100
New +$353K ﹤0.01% 2882

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Renaissance Technologies's INBX Position: Q1 2026 in Review

Renaissance Technologies reduced its Inhibrx (INBX) stake by 4.6% in Q1 2026, selling an estimated $179K and leaving 50,183 shares worth $3.37M. The position accounts for 0.01% of the portfolio, ranked #1596.

Renaissance Technologies first reported a position in INBX in Q3 2024 and has held it in 4 quarters since. The position peaked at $4.16M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Renaissance Technologies held 50,183 shares of Inhibrx worth $3.37M as of Q1 2026.
  • Renaissance Technologies sold 2,417 Inhibrx shares in Q1 2026, an estimated $179K.
  • Inhibrx made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1596 holding.
  • Renaissance Technologies first reported a position in Inhibrx in Q3 2024 and has held it in 4 quarters since.
  • Renaissance Technologies's Inhibrx position peaked at $4.16M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.